Mary Beth Scholand MD
Critical Care Medicine, Pleural Disease
Assistant Professor, Internal Medicine, University of Utah School of
Join to view full profile
50 N Medical DrSalt Lake City, UT 84132
Phone+1 801-581-7806
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mary Beth Scholand, MD is a pulmonologist in Salt Lake City, Utah. She is currently licensed to practice medicine in Utah, Montana, and Montana. She is an Assistant Professor at University of Utah School of.
Education & Training
University of Utah HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2002
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1993- WashU MedicineClass of 1990
Certifications & Licensure
UT State Medical License 2001 - 2028
MT State Medical License 2022 - 2024- MT State Medical License 2022 - 2024
ID State Medical License 2020 - 2023
WY State Medical License 2022 - 2023
CO State Medical License 1993 - 2005
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan.Julie Williamson, Kristen Kelley, Mary Beth Scholand, Christine Crossno, Shelly Hummert
Breast Cancer Research and Treatment. 2025-04-01 - Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study.Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim A Wuyts, R Gisli Jenkins
Therapeutic Advances in Respiratory Disease. 2024-11-08 - 28 citationsDifferentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.Kristine M Erlandson, Linda N Geng, Caitlin A Selvaggi, Tanayott Thaweethai, Peter Chen
Annals of Internal Medicine. 2024-09-01
Press Mentions
Comprehensive COVID-19 ‘Long-Hauler’ Clinic Opens at U of U HealthJune 3rd, 2021- Joint 3i/U2M2 Project Grants Open Pathways for Infectious Disease ResearchApril 29th, 2021
Officials Break Ground on U. Facility Expected to Increase University Hospital's CapacityJune 30th, 2017
